Brief: Icosavax Announces Positive Interim Results From Phase 1 Clinical Trial Of IVX-A12
22/05/2023 22:32
May 22 (Reuters) - Icosavax Inc ICVX.O :
* ICOSAVAX INC- ANNOUNCED POSITIVE INTERIM RESULTS FROM
PHASE 1
CLINICAL TRIAL OF IVX-A12 AGAINST RSV AND HMPV IN OLDER ADULTS
Further company coverage: ICVX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Icosavax
See all newsU.S. RESEARCH ROUNDUP- Adobe, Costco Wholesale, Synopsys
Press Digest: British Business - Dec. 13
Brief: Icosavax Required To Pay Astrazeneca Finance And Holdings Termination Fee Of $27.2 Mln
Deals of the day-Mergers and acquisitions
France, Germany shares hit record highs, but give up gains after U.S CPI (updated)